US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,590.09

+40.712.63%

Number of Gainers:14

Number of Losers:5

Number of Flat:- -

PE:- -

High:1,590.49

Open:1,552.03

Low:1,552.03

Close:1,549.38

Volume:191.40M

Turnover:7.31B

Market Cap:1.30T

Float Cap:1.28T

Loading ...

Pfizer Sept Quarter Net Profit 1.89 Billion Rupees

Pantera Minerals Defines New Exploration Targets at Gillham Project

Moderna Inc. Stock Rallies 6.7%, Outperforms Peers

Moderna's Cost-Cutting, Pipeline Catalysts Set Stage for 2026 Upside, UBS Says

MT Newswires Live

AstraZeneca Advances Tuesday, Outperforms Market

Inovio Shares Sink After Pricing $25M Public Offering

BioNTech SE publishes presentation outlining research progress and market strategy

BUZZ-Inovio Pharma falls on $25 mln stock sale

Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market

NanoViricides prices 3.57M shares at $1.68 in registered direct offering

Inovio 13.16M share Spot Secondary priced at $1.90

Inovio Announces Pricing of $25 Million Public Offering

THOMSON REUTERS

Inovio Pharmaceuticals Inc - Prices Public Offering of 13,158,000 Shares at $1.90 Each

THOMSON REUTERS

AstraZeneca Shares Hit Record High After Earnings Beat, U.S. Price Deal -- Market Talk

NanoViricides Inc. Launches Private Placement of Warrants in $6 Million Deal

Cautious Optimism: Pfizer’s Strategic Initiatives and Clinical Trials Amidst Oncology Competition

Rothschild & Co Redburn Adjusts Price Target on Moderna to $36 From $53, Maintains Neutral Rating

MT Newswires Live

Johnson & Johnson's Zhou Mintao: No Longer Innovating Alone, Fully Integrating into China's Innovation Ecosystem

Rockwell Medical Appoints Rashad Brown as Vice President of Manufacturing and Supply Chain

Vir Biotechnology (VIR) Gets a Buy from TD Cowen

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1590.0883,"timestamp":1762894799999,"preClose":1549.3801,"halted":0,"volume":191399507,"delay":0,"changeRate":0.026274,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":40.70813,"latestTime":"11-11 16:00:00 EST","open":1552.0281,"high":1590.4893,"low":1552.0264,"amount":7312020671.461013,"amplitude":0.024825,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762957800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.945571,"peRate":20.435806,"turnoverRate":0.012458,"increases":14,"decrements":5,"flats":0,"marketCap":1301159740018,"floatMarketCap":1280084119846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1590.4893,"amplitude":0.024825,"preClose":1549.3801,"low":1552.0264,"pbRate":"3.945571","latestPrice":1590.0883,"volume":191399507,"delay":0,"open":1552.0281,"prevYearClose":1274.8187,"prevWeekClose":1534.8367,"prevMonthClose":1528.0375,"prevQuarterClose":1508.8958,"fiveDayClose":1526.5634,"twentyDayClose":1560.842,"sixtyDayClose":1491.7644,"secType":"PLATE","market":"US","turnoverRate":0.012458,"peRate":20.435806,"marketCap":1301159740018,"floatMarketCap":1280084119846,"timestamp":1762894799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":14,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582320313","title":"Pfizer Sept Quarter Net Profit 1.89 Billion Rupees","url":"https://stock-news.laohu8.com/highlight/detail?id=2582320313","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582320313?lang=en_us&edition=fundamental","pubTime":"2025-11-12 19:07","pubTimestamp":1762945671,"startTime":"0","endTime":"0","summary":"Nov 12 (Reuters) - Pfizer Ltd ::*SEPT QUARTER NET PROFIT 1.89 BILLION RUPEES*SEPT QUARTER REVENUE FROM OPERATIONS 6.42 BILLION RUPEES  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 12-NOV-202510:57:55 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nRSD4LrLY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1066051498.USD","SG9999001176.USD","LU0321505439.SGD","SG9999002224.SGD","BK4581","IE00BLSP4452.SGD","IE0002270589.USD","PFE","BK4533","LU0289739699.SGD","LU1894683264.USD","BK4007","LU1883839398.USD","BK4588","BK4592","LU1057294990.SGD","LU0122379950.USD","BK4599","IE00BBT3K403.USD","LU0306807586.USD","SG9999001176.SGD","SG9999002232.USD","LU0234572021.USD","BK4568","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999003800.SGD","BK4585","LU0225284248.USD","LU0456855351.SGD","LU0985481810.HKD","LU0058720904.USD","LU0170899867.USD","LU0225771236.USD","IE000M9KFDE8.USD","SG9999013999.USD","LU0306806265.USD","LU0321505868.SGD","BK4550","LU1066053197.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU1894683348.USD","SG9999011175.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2582318367","title":"Pantera Minerals Defines New Exploration Targets at Gillham Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2582318367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582318367?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:48","pubTimestamp":1762897683,"startTime":"0","endTime":"0","summary":"Pantera Minerals Ltd. ( ($AU:PFE) ) has provided an update. Pantera Minerals Ltd. has identified seven priority exploration targets at its Gillham ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pantera-minerals-defines-new-exploration-targets-at-gillham-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pantera-minerals-defines-new-exploration-targets-at-gillham-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","BK4007","LU1057294990.SGD","IE00B19Z3B42.SGD","BK4585","LU0170899867.USD","IE0002270589.USD","LU0225771236.USD","SG9999013999.USD","LU0122379950.USD","LU1066051498.USD","LU1023059063.AUD","SG9999001176.USD","IE000M9KFDE8.USD","LU0306807586.USD","LU1066053197.SGD","BK4592","LU1894683264.USD","LU1894683348.USD","LU0058720904.USD","LU0289739699.SGD","SG9999003800.SGD","BK4568","BK4581","LU1883839398.USD","SG9999001176.SGD","PFE","LU0321505868.SGD","LU0306806265.USD","IE00BLSP4452.SGD","BK4109","LU0985481810.HKD","BK4550","BK4599","LU0234572021.USD","IE00B19Z3581.USD","LU0321505439.SGD","BK4588","LU0868494617.USD","LU0225284248.USD","LU0456855351.SGD","SGXZ57979304.SGD","SG9999011175.SGD","BK4534","MTX","SG9999002232.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","BK4533"],"gpt_icon":0},{"id":"2582390617","title":"Moderna Inc. Stock Rallies 6.7%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2582390617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582390617?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:32","pubTimestamp":1762896720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 6.7% to $26.41 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.2% to 47,927.96 and the NASDAQ Composite Index falling 0.3% to 23,468.30.This was the stock's fourth consecutive day of gains.Moderna Inc. closed 46.0% below its 52-week high of $48.92, which the company achieved on January 7th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.9% to $193.83, Pfizer Inc. rose 4.6% to $25.51, and Gilead Sciences Inc. rose 3.73% to $122.56.Trading volume totaled 11.5 million, compared to the 50-day average of 11.7 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","SGXZ57979304.SGD","LU0225771236.USD","LU0234572021.USD","IE0002270589.USD","BK4534","IE00B19Z3B42.SGD","BK4551","LU0321505868.SGD","SG9999001176.SGD","LU0321505439.SGD","LU1894683348.USD","LU1894683264.USD","MRNA","LU0985481810.HKD","LU1066051498.USD","LU0306806265.USD","LU0170899867.USD","LU0289739699.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU1883839398.USD","BK4548","BK4532","LU0225284248.USD","LU0868494617.USD","SG9999011175.SGD","IE00BBT3K403.USD","LU0456855351.SGD","LU1057294990.SGD","LU1066053197.SGD","SG9999001176.USD","SG9999002232.USD","IE000M9KFDE8.USD","LU1023059063.AUD","BK4592","BK4568","BK4139","BK4007","BK4550","BK4501","BK4581","SG9999013999.USD","LU0306807586.USD","BK4599","BK4585","BK4533","SG9999002224.SGD","LU0122379950.USD"],"gpt_icon":1},{"id":"2582139403","title":"Moderna's Cost-Cutting, Pipeline Catalysts Set Stage for 2026 Upside, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2582139403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582139403?lang=en_us&edition=fundamental","pubTime":"2025-11-12 04:02","pubTimestamp":1762891371,"startTime":"0","endTime":"0","summary":"Moderna  beat COVID-19 vaccine sales expectations in Q3, with management confident in meeting full-year 2025 guidance despite lower vaccination rates, UBS said in a note Monday.Operational efficiencies helped costs come in well below estimates, positioning Moderna to exceed its 2025 cost reduction targets by around $1 billion on a GAAP basis, the firm said.UBS sees Moderna's oncology franchise as an undervalued growth driver, citing key data readouts in 2026 for its melanoma and renal cell carcinoma vaccines.Risks outlined by UBS include lower vaccine uptake for COVID-19, competition, and clinical pipeline setbacks, as well as possible regulatory changes.UBS maintained the company's buy rating and $40 price target.Shares of Moderna rose over 4% in recent Tuesday trading.Price: 25.94, Change: +1.18, Percent Change: +4.75","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4588","BK4533","BK4532","BK4551","BK4568","BK4139","BK4501","BK4535","BNTX","SSI","BK4534","MRNA","BK4585"],"gpt_icon":0},{"id":"2582763395","title":"AstraZeneca Advances Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2582763395","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582763395?lang=en_us&edition=fundamental","pubTime":"2025-11-12 01:06","pubTimestamp":1762880760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares advanced 2.59% to GBP134.66 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 1.15% to 9,899.60.AstraZeneca PLC hit a new 52-week high, surpassing its previous peak of GBP132.06, which the company reached on November 10th.Trading volume totaled 1.4 million, compared to the 50-day average of 2.1 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4007","LU2462157665.USD","LU2417539215.USD","LU0109394709.USD","BK4588","LU1829250122.USD","LU2456880835.USD","BK4585","AZN","LU0320765992.SGD","LU2236285917.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2582393460","title":"Inovio Shares Sink After Pricing $25M Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2582393460","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582393460?lang=en_us&edition=fundamental","pubTime":"2025-11-12 00:21","pubTimestamp":1762878060,"startTime":"0","endTime":"0","summary":"Shares of Inovio Pharmaceuticals fell after the company priced a $25 million public offering.The stock slid 6.5% to $2.01 on Tuesday. Despite losing more than 60% of their value over the past year, shares have gained roughly 35% in the past three months.Ahead of the opening bell, the drugmaker said it plans to sell about 13.2 million shares of common stock at $1.90 apiece. Inovio will also grant underwriters a 30-day option to purchase up to nearly 2 million shares at the offering price, minus underwriting fees.Piper Sandler & Co. is acting as sole manager for the offering, and all shares are being sold by Inovio. The offering is expected to close on or about Nov. 12.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","INO","BK4568","BK4139"],"gpt_icon":0},{"id":"2582624843","title":"BioNTech SE publishes presentation outlining research progress and market strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2582624843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582624843?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:14","pubTimestamp":1762870480,"startTime":"0","endTime":"0","summary":"BioNTech SE has published a new corporate presentation detailing its latest estimates for revenues, research and development expenses, selling, general and administrative expenses, and capital expenditures related to its operating activities. The presentation also outlines upcoming payments related to litigation settlements, as well as expectations for future scientific and investor presentations. The document references internal research and data obtained from third-party sources, while noting that these have not been independently verified. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief on November ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL8BMxpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","BK4535","BK4568","BK4139","BK4548","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"2582362928","title":"BUZZ-Inovio Pharma falls on $25 mln stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362928","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582362928?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:13","pubTimestamp":1762870419,"startTime":"0","endTime":"0","summary":"** Shares of Inovio Pharmaceuticals INO.O down 7% premarket to $2 after $25 mln follow-on prices. ** Plymouth Meeting, Pennsylvania-based biotech says it sold ~13.2 mln shares at $1.90, a 11.6% discount to stock's last close. ** After the bell Mon, INO reported Q3 results and reiterated it's seeking accelerated approval from U.S. FDA for lead candidate INO-3017 after completing rolling biologics license application submission. , a disease in which benign  tumors called papillomas grow in the air passages leading from the nose and mouth into the lungs. ** 4 of 6 analysts rate the stock \"strong buy\" or \"buy\", 2 rate \"hold\"; median PT is $7.50, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nL6N3WN0RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","BK4583","BK4568","BK4139","BK4127","PIPR"],"gpt_icon":0},{"id":"1100166005","title":"Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1100166005","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100166005?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:52","pubTimestamp":1762869138,"startTime":"0","endTime":"0","summary":"On November 11, shares of pharmaceutical giant AstraZeneca PLC (AZN) rose 2.5% intraday to £134.6, setting a new all-time high. With its market capitalization nearing £210 billion ($282 billion), the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AZN","LU0320765992.SGD","LU0109394709.USD","LU2417539215.USD","LU2236285917.USD","BK1161","09939","BK4007","LU2456880835.USD","LU0889565916.HKD","BK4568","BK4585","LU2462157665.USD","159938","BK1574","LU1829250122.USD","BK1515"],"gpt_icon":0},{"id":"2582628953","title":"NanoViricides prices 3.57M shares at $1.68 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2582628953","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582628953?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:45","pubTimestamp":1762868742,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,57...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-prices-3-57m-shares-at-1-68-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-prices-3-57m-shares-at-1-68-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2582136407","title":"Inovio 13.16M share Spot Secondary priced at $1.90","url":"https://stock-news.laohu8.com/highlight/detail?id=2582136407","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582136407?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:45","pubTimestamp":1762868725,"startTime":"0","endTime":"0","summary":"Inovio (INO) Pharmaceuticals announced the pricing of an underwritten public offering of 13,158,000 shares of its common stock at a public offering...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inovio-13-16m-share-spot-secondary-priced-at-1-90-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inovio-13-16m-share-spot-secondary-priced-at-1-90-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4568","INO","BK4139"],"gpt_icon":0},{"id":"2582364188","title":"Inovio Announces Pricing of $25 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364188?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:40","pubTimestamp":1762868428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUA1XFW0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4568","INO","BK4139"],"gpt_icon":0},{"id":"2582364186","title":"Inovio Pharmaceuticals Inc - Prices Public Offering of 13,158,000 Shares at $1.90 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364186?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:40","pubTimestamp":1762868428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUA1XFW0K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4583","BK4568","INO"],"gpt_icon":0},{"id":"2582364618","title":"AstraZeneca Shares Hit Record High After Earnings Beat, U.S. Price Deal -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2582364618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582364618?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:38","pubTimestamp":1762868280,"startTime":"0","endTime":"0","summary":"1338 GMT - AstraZeneca shares hit their highest level on record after third-quarter earnings last week beat market expectations. A U.S. drug-pricing deal reached last month that eased policy uncertainty also supports gains for the British pharma group, which makes more than 40% of its sales in the U.S. Shares rose 2.5% in early trading after climbing to an all-time intraday high of 134.6 pounds. Shares are now trading at 133.48 pounds, valuing the company at 203.3 billion pounds. AstraZeneca remains the largest U.K.-listed stock by market capitalization. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LU2417539215.USD","BK4588","LU0109394709.USD","LU0889565916.HKD","LU2236285917.USD","BK4568","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","BK4007","LU2456880835.USD","BK4585"],"gpt_icon":0},{"id":"2582361006","title":"NanoViricides Inc. Launches Private Placement of Warrants in $6 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361006","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582361006?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:30","pubTimestamp":1762867825,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has announced a concurrent private placement alongside its registered direct offering, issuing Series A and Series B warrants to purchase up to 3,571,429 shares of common stock each. The Series A Warrants will have an exercise price of $1.75 per share, exercisable six months after issuance and expiring two years later. The Series B Warrants, with an exercise price of $2.00 per share-about a 20% premium to the prior closing price-become exercisable after six months and expire 5.5 years from issuance. The warrants and the shares underlying them will be sold to an institutional investor in a transaction exempt from SEC registration requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL4BNpyr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2582936604","title":"Cautious Optimism: Pfizer’s Strategic Initiatives and Clinical Trials Amidst Oncology Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2582936604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582936604?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:36","pubTimestamp":1762864585,"startTime":"0","endTime":"0","summary":"Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Pfizer, retaining the price target of $32.00. Terence Flynn’s rating is based o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-optimism-pfizers-strategic-initiatives-and-clinical-trials-amidst-oncology-competition-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-optimism-pfizers-strategic-initiatives-and-clinical-trials-amidst-oncology-competition-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683264.USD","BK4568","LU0170899867.USD","LU0267386448.USD","LU1057294990.SGD","SG9999001176.SGD","LU0314104364.USD","SG9999013999.USD","LU0868494617.USD","LU0557290698.USD","BK4534","LU1244550494.USD","LU0234570918.USD","LU0225284248.USD","LU0006306889.USD","LU2028103732.USD","LU2111349929.HKD","PFE","SG9999002224.SGD","SGXZ57979304.SGD","LU2133065610.SGD","IE00BKVL7J92.USD","LU0225771236.USD","LU0158827781.USD","LU0225283273.USD","BK4504","LU1732800096.USD","LU0158827948.USD","LU1668664300.SGD","LU0912757837.SGD","LU2347655156.SGD","LU0122379950.USD","LU1363072403.SGD","LU1883839398.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0971096721.USD","BK4592","SG9999002232.USD","BK4516","BK4127","LU1989772923.USD","LU0306806265.USD","LU1548497426.USD","LU0098860793.USD","BK4533","LU0795875086.SGD","LU1023059063.AUD","LU2089284900.SGD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2582661653","title":"Rothschild & Co Redburn Adjusts Price Target on Moderna to $36 From $53, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2582661653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582661653?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:25","pubTimestamp":1762863956,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $39.32, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4501","BK4551","BK4548","BK4533","BK4585","BK4588","BK4532","BK4139","BK4568","MRNA","BK4534"],"gpt_icon":0},{"id":"1189908099","title":"Johnson & Johnson's Zhou Mintao: No Longer Innovating Alone, Fully Integrating into China's Innovation Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=1189908099","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189908099?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:41","pubTimestamp":1762861305,"startTime":"0","endTime":"0","summary":"\"Surgical robotics is a highly competitive field, but far from saturated,\" said Zhou Mintao, President of Johnson & Johnson MedTech China, during an interview at the 8th China International Import...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNW00.USD","LU1506573853.SGD","LU0985320562.USD","LU2750360641.GBP","IE00BBT3K403.USD","LU1718418525.SGD","LU0070217475.USD","BK4532","IE0034235303.USD","IE000M9KFDE8.USD","LU0203345920.USD","LU0345769128.USD","IE00B3T34201.USD","LU1267930813.SGD","LU1732799900.SGD","LU1032466523.USD","SG9999002224.SGD","LU1162221912.USD","LU1929549753.HKD","LU1221951129.SGD","LU1280957306.USD","LU0912757837.SGD","LU2471134879.HKD","LU2129689514.USD","BK4559","LU1032955483.USD","LU1585245621.USD","LU1221951046.USD","LU2750360997.AUD","LU1244550494.USD","LU1674673428.USD","IE00B3PB1722.GBP","LU0792757196.USD","BK4504","BK4581","BK4588","IE00BJJMRZ35.SGD","LU0345769631.USD","IE00B2B36J28.USD","IE00B42XCP33.USD","LU0640476718.USD","LU2133065610.SGD","IE00BLSP4452.SGD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","IE0002270589.USD","LU1057294990.SGD","LU0234570918.USD","LU2602419157.SGD","LU2129689605.HKD","LU0320765646.SGD","IE00B19Z3581.USD","LU2505996509.AUD","LU1059921491.USD","LU1066053197.SGD","IE00B1BXHZ80.USD","LU0466842654.USD","LU1023059063.AUD","JNJ","BK4550","LU0098860793.USD","IE00B7SZLL34.SGD","LU2471134796.USD","LU0795875169.SGD","BK4007","IE0002141913.USD","LU1778281490.HKD","BK4568","IE00B19Z3B42.SGD","LU0795875086.SGD","IE00BLSP4239.USD","SG9999001440.SGD","LU0122379950.USD","IE00BDGV0183.EUR","LU0289739699.SGD","LU0203347892.USD","LU2430703178.SGD","LU1430594728.SGD","LU1894683264.USD","LU2505996681.GBP","LU0432979614.USD","LU0345770993.USD","LU2112291526.USD","LU2347655156.SGD","LU2471134523.USD","LU2129689431.USD","LU1261432733.SGD","IE00BVYPNV92.GBP","SG9999002232.USD","LU1074936037.SGD","LU2468319806.SGD","LU1066051225.USD","LU0882574055.USD","LU1914381329.SGD","IE0009355771.USD","LU2592432038.USD","LU2430703095.HKD","LU0889566641.SGD","IE00BFTCPJ56.SGD","LU1935042991.SGD","LU1732800096.USD","IE00BN8TJ469.HKD","BK4585","LU1196500208.SGD","LU2430703251.USD","BK4592","LU0114720955.EUR","LU2089984988.USD","LU1496350502.SGD","BK4534","LU1244550221.USD","LU1066051811.HKD","BK4533","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1674673691.USD","LU0345770308.USD","LU1244550577.SGD","LU1894683348.USD","LU1066051498.USD","LU0058720904.USD","IE00BFXG1179.USD","LU1061106388.HKD","LU2471134952.CNY","LU0234572021.USD"],"gpt_icon":0},{"id":"2582685653","title":"Rockwell Medical Appoints Rashad Brown as Vice President of Manufacturing and Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=2582685653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582685653?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:00","pubTimestamp":1762858828,"startTime":"0","endTime":"0","summary":"Rockwell Medical Inc. has appointed Rashad Brown as Vice President of Manufacturing and Supply Chain. Brown brings over 20 years of experience in manufacturing operations, procurement, warehouse management, and supply chain optimization, with previous leadership roles at Abbott Laboratories, Fresenius Medical Care, and Hearing Lab Technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire  on November 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL2Qtvsj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","SG9999004303.SGD","IE00BJT1NW94.SGD","SGXZ23171101.USD","IE00BJJMRZ35.SGD","LU1721429741.USD","LU2468319806.SGD","LU1023059063.AUD","BK4585","LU1691799644.USD","LU1989763427.SGD","LU2237957902.USD","LU2133065610.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","BK4588","BK4568","LU0058720904.USD","RMTI","BK4082","LU1914381329.SGD","BK4592","IE00BFTCPJ56.SGD","BK4581","LU1721429402.USD","SG9999002232.USD","LU1061106388.HKD","LU0266013472.USD","LU1057294990.SGD","LU0868494617.USD","LU0882574055.USD","LU2089984988.USD","LU2324357040.USD","IE0009355771.USD","LU0170899867.USD","LU0122379950.USD","LU2237957811.SGD","ABT","LU0114720955.EUR","LU0234572021.USD","LU1989763690.USD","IE0002141913.USD","LU2112291526.USD","LU2211815571.USD","IE00B2B36J28.USD","BK4566","LU0289739699.SGD","BK4504","BK4533"],"gpt_icon":0},{"id":"2582362351","title":"Vir Biotechnology (VIR) Gets a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582362351?lang=en_us&edition=fundamental","pubTime":"2025-11-11 16:58","pubTimestamp":1762851524,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Phil Nadeau maintained a Buy rating on Vir Biotechnology yesterday. The company’s shares closed yesterday at $5.37. According to T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-gets-a-buy-from-td-cowen-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-gets-a-buy-from-td-cowen-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4585","BK4568","BK4139","BK4127","BK4566","COWN","VIR","TD","BK4535"],"gpt_icon":0}],"pageSize":20,"totalPage":24,"pageCount":1,"totalSize":467,"code":"91000000","status":"200"}]}}